🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

UTSW reporting on prostate MRI in bore biopsy to predict index tumor nodules. UTSW GU Pathology

I am ready to rock!

Administration aside, I am still signing out cases, including expert consult cases.

New residents, new talents and the future of our profession. #tuftsmcpathology

Quality is vital to what we do in the lab! Congrats to 2 presentations, lead by Bernie and Nick, at Tufts Quality Academy Summer 2019! @TuftsMCPath

Hope this book will help residents and fellows learn and like prostate pathology .

Hope this book will help residents and fellows learn and like prostate pathology!

Teaching “New Things” in GU with MING was fun again at CAP 2019. Thank you participants for great questions and joining! CAPathologists

Tufts Pathology's first grand rounds lecture was delivered, deservingly, by Dr. Arthur Tischler, the foremost researcher and pathologist on paraganglioma and pheochromocytoma.@TuftsMCPath Tufts Medical Center

Glad to see Tufts residents at the CAP meeting in Orlando.

Very practical!

Fun to have recorded a 10 minute youtube tutorial with Dr. Rajal Shah. Look forward another eecording.

recording. To go back to Dallas, a city I called home until 7 months ago.

GUPS companoin meeting starts with Dr. Michelle Hirsch's talk on bladder cancer #USCAP2022

Dr. Larry True received GUPS inaugural lifetime achievement award! Way to go! Thank you for your many contributions to GU path world ⁦GU Pathology Society (GUPS)⁩ #gupath

Tufts Medical Center Pathology resident Maria Teresa presents her study on TIL in lung cancer.

Interested in a 1-day slide session with myself and Dr. Ming Zhou, MD, PhD from Tufts Medical Center on GU Pathology? California Tumor Tissue Registry course cttr.org/cms/ featuring kidney, bladder, prostate pathology. Dec 4th! #GUpath

GUPS members voiced their opinion on reclassifying Grade Group 1 prostate cancer as non-cancer. 81.7% opposed, 13.8% supported and 4.6% uncertain about, removing the cancer label from GG1 cancer. Read more: authors.elsevier.com/a/1g7zZ3r93nVD…. Thank you all for participating in this survey.

Pathology is not just about interesting cases. It is also about fellowship. NYU welcomes Dr Michelle Hirsch as a visiting professor at the invitation of Drs. Fang-ming Deng, Faye Chen and Mamta Gupta. I tagged along for good food.